C a n n a b i s S n a p s h o t
Cannabis, Cannabis L, is the botanical name of a plant in the cannabaceae small family of plants, one of the oldest cultivated and legal crops.
Cannabis has served as a potent and versatile plant for both its health benefits and multiple commercial applications over the course of human history.
Some date it back to 26,900 BC from a hemp rope found in Czechoslovakia in 1997. Others cite Mongolia in 1200 BC or Egypt in 3700 BC. The first record of its medicinal use in China was around 4000 BC.
Important aspects of the cannabis plant, in both form and function show up in pairs ( i.e. two’s). Based on its use, cannabis is commonly divided into two main categories as marijuana and hemp and includes both.
Marijuana (pictured left), contains the psychoactive property tetrahydrocannabinol (THC). Hemp, which is more fibrous and has trace levels to no psychoactive properties, is often used in the manufacture of products such as, rope, clothing and paper (pictured below)
The two main classic sub-species of marijuana are sativa and indica. However, there are also several hybrid combinations of the two.
The two most well known of the over-100 molecular compounds in the cannabis plant are, as previously mentioned, tetrahydrocannabinol (THC) and the non-psychoactive cannabidiol (CBD), present in both marijuana and hemp.
Marijuana is also biphasic. Depending on how you use it, it can calm you down or freak you out; make you strong or decrease your vitality.
Wellness and Cannabis
The medicinal use of marijuana is a world apart from its recreational use. In many cases, the lower the amount of THC used in any medicinal formulation, the greater the desired effect. The saying is: Start low; go slow. Treatment is never one-size-fits-all because the current status and interaction of someone’s body, mind and soul are primary considerations.
The cannabis plant is an “adaptogen” type of plant as are many others including, (but not limited to), American ginseng, yerba mate, reishi mushrooms, rosemary and aloe vera. All adaptogen plants are: 1) non-toxic, 2) respond as needed to reduce stress, and 3) have the ability to stimulate and balance bodily functions by either decreasing hyperactive systems or increasing and strengthening weaker ones.
Historically, the whole of the marijuana plant was used for the purpose of making a beneficial impact on a person’s overall, general condition beyond symptom management. This is a different thought process and approach from conventional medicine that will isolate specific plant compounds to manufacture a pharmaceutical to target only one organ or bodily system.
When the whole plant is used medicinally, a synergistic benefit occurs in the body via the interaction of the THC, CBD and its other less understood compounds. Also known as the entourage effect, this synergistic action accounts for why cannabis’ therapeutic use can provide relief to a wide variety of conditions.
There are many different delivery systems available for using cannabis. They include sublingual tinctures, concentrated extracts, inhalation via smoking and vaping, suppositories and edibles. The ratio of CBD to THC in any given formula depends first on the person, and secondly on the issues to be addressed.
British Journal of Clinical Pharmacology
2013 Feb;75(2):323-33. doi: 10.1111/j.1365-2125.2012.04341.x.
Fernández-Ruiz J1, Sagredo O, Pazos MR, García C, Pertwee R, Mechoulam R, Martínez-Orgado J.“Cannabidiol (CBD) is a phytocannabinoid with therapeutic properties for numerous disorders exerted through molecular mechanisms that are yet to be completely identified. CBD acts in some experimental models as an anti-inflammatory, anticonvulsant, anti-oxidant, anti-emetic, anxiolytic and antipsychotic agent, and is therefore a potential medicine for the treatment of neuroinflammation, epilepsy, oxidative injury, vomiting and nausea, anxiety and schizophrenia, respectively. The neuroprotective potential of CBD, based on the combination of its anti-inflammatory and anti-oxidant properties, is of particular interest and is presently under intense preclinical research in numerous neurodegenerative disorders. In fact, CBD combined with Δ(9)-tetrahydrocannabinol is already under clinical evaluation in patients with Huntington’s disease to determine its potential as a disease-modifying therapy.”(1)
(1) Cannabidiol for neurodegenerative disorders https://www.ncbi.nlm.nih.gov/pubmed/22625422
Pain relief. THC is the active ingredient in cannabis that blocks pain. Many who suffer chronic pain conditions get relief from THC that they could not get otherwise.
Appetite stimulant. THC works in the brain to stimulate appetite. It is helpful for those suffering from wasting diseases or undergoing chemotherapy.
Sleep aid. THC in small therapeutic doses helps induce relaxation and promote sleep.
Anti-inflammatory. When THC interacts with the central nervous system, it changes certain proteins and disrupts genetic expression. The THC acts as a strong anti-inflammatory. This property is especially helpful for fighting autoimmune diseases where inflammation, as an expression of diseased genetics, causes severe pain.
Anti-toxin. Amyloid beta proteins are the root cause of Alzheimer’s disease. These proteins build up in brain cells and block communication. THC removes these proteins from damaged brain cells, preventing the amyloid plaque from building up.
Anti-cancer. Studies have shown THC has an effect on certain cancer cells that is promising for a potential cure. THC enters the cancer cells and causes them to commit suicide. THC does not have the same effect on normal cells.
Anxiety reduction. THC boosts the brain’s own natural system for stress reduction by mimicking endocannabinoids, a natural brain chemical. Endocannabinoids regulate anxiety by increasing the level of cannabinoids in the brain.
The Endocannabinoid System
All animals with a spine have something called an endogenous cannabinoid system, aka the endocannabinoid system (ECS). This system is the physiological reason why cannabis can impact human health and wellbeing.
THC, first isolated in 1964, is what led to the scientific discovery in the early 1990’s of this previously unknown system, obviously named referencing the cannabinoid chemical compounds most often associated with cannabis, yet also found in other plants.
The ECS is a complex genetically-coded, molecular-signaling system found in mammals. It is considered critical to establishing homeostasis (balance of health) and protecting against stressors. A recent breakthrough in understanding human physiology, its importance is said to be hard to overstate.
Atypically, the ECS has a bi-modal effect, affecting both the central nervous system and peripheral nervous system. Because it is a lipid (fat-soluble) system, the ECS mediates stress. Its overall value is as a “calm down” message to the brain and body.
The ECS is made up of a large network consisting of three main parts: 1) cannabinoid receptors, 2) endocannabinoid molecules and 3) the enzymes that break them down.
The thousands of receptors are located inside cells of our brain, lungs, etc. and virtually every tissue throughout the body. They are the lock and the endocannabinoids are the key to the body’s naturally functioning system.
The receptors act as an internal communication system picking up information for the purpose of neurotransmitter-message signaling for all physiological processes. Unique messages are sent across the receptor system to normalize body processes to homeostasis, i.e. proper function.
The most studied of the ECS receptors are called CB1 and CB2. CB1’s are mostly in the brain and CB2’s are largely connected to the immune system but are also found in the brain for neuro-protective purposes when it is injured.
Endocannabinoids are the naturally occurring molecular-chemical compounds made on-demand in our body. They bind to the receptors to become neurotransmitters. The best known of these compounds are anandamide, which binds to CB1 receptors, and 2-AG, that binds to CB2 receptors.
Anandamide and 2-AG are accompanied by a naturally occurring internal control system of enzymes: FAAH for anandamide and MAGL for 2-AG.
Underlying the human ECS is what is called endocannabidiol “tone.” Over time the ECS wears down due to the accumulation of stressors from someone’s lifestyle and diet. Neurologist and medical scientist, Dr. Ethan Russo coined the concept of Clinical Enndocannabinoid Deficiency (CECD) (1) to describe this deficiency.
When our bodies exhibit CECD, they fail to produce sufficient anandamide and/or 2-AG. This imbalance in the ECS negatively impacts its mission of regulating every bodily process to a state of balance, i.e. homeostasis. Dr. Russo found that such deficiency is at the root of hard to resolve issues like fibromyalgia, Irritable Bowel Syndrome (IBS) and migraines. (2)
The good news is, we can boost the building blocks to the ECS to increase the body’s internal manufacture of anandamide and 2-AG. Leafy greens, omega-3 foods and supplements, exercise, meditation, acupuncture, chiropractic, cranial sacral therapy, and probiotics all contribute to building and maintaining a healthy ECS.
This is where whole-plant cannabis also comes in; its value to the ECS, as mentioned, is as a “lock and key” system. Scientists found that cannabis mimics the same regulating effects on the CB1 and CB2 receptors as the naturally occurring anandamide and 2-AG. Therapeutic dosing of phyto (plant) cannabinoids can re balance a deficient ECS.
THC, like anandamide, binds to the CB1 (mostly brain) receptors. CBD, on the other hand, binds to receptors 5HT 1A and serotonin, fatty acid binding proteins and peroxisome proliferator-activated receptor (PPARS), mostly immune-related receptors.
CBD additionally protects and regulates neurotransmitter function and alters the binding of THC to CB1 receptors, lowering, the overall psychoactive effect, and therefore the potential for anxiety, psychotic effects, and certain cognitive deficits.
Complex whole-plant cannabis mixtures in the ECS have the power to cast a broad net, and have the capacity to modify many different bodily functions (multi-modal). Such mixtures can modify complex disorders of behavior, inflammation, and immunity that otherwise have lacked response to a pharmaceutical’s single-drug approach targeting only one organ or system.
The ECS of the naturally-produced molecules of anandamide and 2-AG (and the cannabinoids that mimic them) are best characterized as molecules that help us to eat, sleep, relax, forget and protect. Effects are real and extraordinarily safe.
(1) Dr. Ethan Russo interview. https://vimeo.com/168059727
(2) Clinical endocannabinoid deficiency (CECD) https://www.ncbi.nlm.nih.gov/pubmed/18404144
Both hemp and marijuana enjoy a rapid rise in recognition and respect yet in the United States only hemp has broad legality. Today, growing industrial hemp (the more fibrous species of the plant) is legal in the United States and is increasingly used in the manufacture of clothing, food, paper, rope and CBD oil.
Despite its far-reaching therapeutic effects for all species of animals, marijuana has been out of favor (for less than 100 years) in the U.S due to its psychoactive compounds.
Yet from mid 19th to early 20th century, marijuana could be found in any number of pharmaceutical products sold openly to the public. However, today, it may be spoken of in hushed tones, due largely to the stigma left by the Marahuana Tax Act of 1937. (1)
In 1970, the U.S. Congress passed the Controlled Substance Act designating marijuana a “Schedule 1” drug of the same category as dangerous drugs such as heroin, the criteria of which are: no accepted medical value, is not safe for medical use, and is highly addictive.
How did such a beneficial plant get so vilified? Interesting timing, that, a 1936 movie, Reefer Madness, (2) immediately preceded the passing of the 1937 Marahuana Tax Act ( their actual spelling).
At the time of this writing, cannabis is legal recreationally and/or medicinally in 30 states (Vermont most recent) and DC with most being “medical-marijuana” only.
Alaska, Oregon, California, Colorado, Massachusetts, Maine, Nevada, Vermont, Washington, and Washington, DC are legal for both “medical” and recreational use. Legal access of both varies widely from state to state.
(1) Marahuana Tax Act 1937 history http://www.druglibrary.org /schaffer/hemp/history/mustomj1.html Document http://www.druglibrary.org/schaffer/hemp/taxact/mjtaxact.htm
(2) Reefer Madness https://www.youtube.com/watch?v=yEx0Hvojwm4